[HTML][HTML] Nanoparticle-based delivery systems for vaccines

R Bezbaruah, VP Chavda, L Nongrang, S Alom… - Vaccines, 2022 - mdpi.com
Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional
vaccinations may have low immunogenicity and, in most situations, only provide partial …

Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications

MN Huda, M Nafiujjaman, IG Deaguero… - ACS biomaterials …, 2021 - ACS Publications
Exosomes are cell-derived vesicles containing heterogeneous active biomolecules such as
proteins, lipids, mRNAs, receptors, immune regulatory molecules, and nucleic acids. They …

[HTML][HTML] Nanotechnology advances in the detection and treatment of cancer: an overview

S Mosleh-Shirazi, M Abbasi, M reza Moaddeli… - …, 2022 - ncbi.nlm.nih.gov
Over the last few years, progress has been made across the nanomedicine landscape, in
particular, the invention of contemporary nanostructures for cancer diagnosis and …

Nanomedicines accessible in the market for clinical interventions

V Gadekar, Y Borade, S Kannaujia, K Rajpoot… - Journal of controlled …, 2021 - Elsevier
Nanomedicines refers to nanotechnology inspired pharmaceutical products often referred to
as 'nanopharmaceuticals.'It has displayed commendable potential in enhancing therapeutic …

[HTML][HTML] Challenges in development of nanoparticle-based therapeutics

N Desai - The AAPS journal, 2012 - Springer
In recent years, nanotechnology has been increasingly applied to the area of drug
development. Nanoparticle-based therapeutics can confer the ability to overcome biological …

PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect

S Acharya, SK Sahoo - Advanced drug delivery reviews, 2011 - Elsevier
As mortality due to cancer continues to rise, advances in nanotechnology have significantly
become an effective approach for achieving efficient drug targeting to tumour tissues by …

PLGA-based nanoparticles as cancer drug delivery systems

FS Tabatabaei Mirakabad, K Nejati-Koshki… - Asian Pacific Journal …, 2014 - koreascience.kr
Poly (lactic-co-glycolic acid)(PLGA) is one of the most effective biodegradable polymeric
nanoparticles (NPs). It has been approved by the US FDA to use in drug delivery systems …

Vitamin E TPGS as a molecular biomaterial for drug delivery

Z Zhang, S Tan, SS Feng - Biomaterials, 2012 - Elsevier
d-α-tocopheryl polyethylene glycol succinate (Vitamin E TPGS, or simply TPGS) is a water-
soluble derivative of natural Vitamin E, which is formed by esterification of Vitamin E …

[HTML][HTML] Manufacturing techniques and surface engineering of polymer based nanoparticles for targeted drug delivery to cancer

Y Wang, P Li, T Truong-Dinh Tran, J Zhang, L Kong - Nanomaterials, 2016 - mdpi.com
The evolution of polymer based nanoparticles as a drug delivery carrier via pharmaceutical
nano/microencapsulation has greatly promoted the development of nano-and micro …

Hybrid nanoparticles for detection and treatment of cancer

MJ Sailor, JH Park - Advanced materials, 2012 - Wiley Online Library
There is currently considerable effort to incorporate both diagnostic and therapeutic
functions into a single nanoscale system for the more effective treatment of cancer …